Fortitude Family Office »

Kalvista Pharmaceuticals shares owned by Fortitude Family Office

Quarter-by-quarter ownership of Kalvista Pharmaceuticals (KALV) shares owned by Fortitude Family Office from 13F filings

Historical chart of Fortitude Family Office investment in Kalvista Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Kalvista Pharmaceuticals held by Fortitude Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kalvista Pharmaceuticals by Fortitude Family Office

Quarter filed Position value Share count Share price at filing
2024-09-30 $35 3 11.67
2024-06-30 $35 3 11.67
2024-03-31 $36 3 12.00
2023-12-31 $36 3 12.33

More positions owned by Fortitude Family Office

Apple Stock (AAPL)
Knight-swift Transn Hldgs Inc Cl A Stock (KNX)
Ishares Core S&p 500 Etf Etf (IVV)
Ishares Core Msci International Developed Markets Etf Etf (IDEV)
Vanguard Mid-cap Etf Etf (VO)
Ishares Tips Bond Etf Etf (TIP)
Dimensional Emerging Markets Core Equity 2 Etf Etf (DFEM)
Avantis U.s. Large Cap Value Etf Etf (AVLV)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Ishares Core S&p Small Cap Etf Etf (IJR)
Wisdomtree Floating Rate Treasury Fund Etf (USFR)
Avantis International Small Cap Value Etf Etf (AVDV)
Ishares Msci Emerging Markets Ex China Etf Etf (EMXC)
Jpmorgan Ultra-short Income Etf Etf (JPST)
Kkr & Co Stock (KKR)

View all positions for Fortitude Family Office

Top funds holding Kalvista Pharmaceuticals

VR Adviser
Tang Capital Management
Suvretta Capital Management
Vestal Point Capital
Frazier Life Sciences Management
Capital World Investors
BlackRock
BlackRock
Vanguard Group
Boxer Capital
Dr. Jeffrey R. Jay, M.D.
Saturn V Capital Management
MPM Oncology Impact Management
Emerald Advisers
Geode Capital Management

View all funds holding Kalvista Pharmaceuticals